Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFTAZIDIME vs CEFTRIAXONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFTAZIDIME vs CEFTRIAXONE: Safety Overview

Metric CEFTAZIDIME CEFTRIAXONE
Total FAERS Reports 3,158 19,418
Deaths Reported 696 2,926
Death Rate 22.0% 15.1%
Hospitalizations 1,503 9,596
Average Patient Age 52.0 yrs 55.8 yrs
% Female Patients 43.3% 47.2%
FDA Approval Date Apr 28, 1989 Apr 12, 2007
Manufacturer Hospira, Inc. Baxter Healthcare Company
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued Discontinued